Comparable activating mutations occur at the equivalent position in the kinase domain of c-KIT (D816V) in gastrointestinal stromal tumours (GIST) and acute myeloid leukaemia (AML), and in the kinase domain of FLT3 (D835Y) in AML [4, 25]. This evidence concerns the gene KIT and acute myeloid leukemia.